Skip to Content

IL 3581 (Theophylline extended release 300 mg)

Pill imprint IL 3581 has been identified as Theophylline extended release 300 mg.

Theophylline is used in the treatment of asthma, acute; apnea of prematurity; asthma, maintenance and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Theophylline extended release 300 mg IL 3581
Theophylline extended release 300 mg IL 3581
Theophylline extended release
IL 3581
300 mg
Prescription only
Drug Class:
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Inwood Laboratories Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00182-1400 Goldline Laboratories Inc
00677-0817 URL Pharma, Inc.(now Sun Pharma)
00904-1612 Major Pharmaceuticals
00456-4330 Forest Laboratories, Inc.
00603-5946 Qualitest Pharmaceuticals
54569-2483 A-S Medication Solutions, LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.